Viewing Study NCT02242305


Ignite Creation Date: 2025-12-25 @ 3:19 AM
Ignite Modification Date: 2026-03-02 @ 10:54 PM
Study NCT ID: NCT02242305
Status: COMPLETED
Last Update Posted: 2017-07-27
First Post: 2014-09-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-11-01
Start Date Type: ACTUAL
Primary Completion Date: 2009-07-20
Primary Completion Date Type: ACTUAL
Completion Date: 2009-07-20
Completion Date Type: ACTUAL
First Submit Date: 2014-09-16
First Submit QC Date: None
Study First Post Date: 2014-09-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-03-29
Results First Submit QC Date: None
Results First Post Date: 2017-07-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-07-26
Last Update Post Date: 2017-07-27
Last Update Post Date Type: ACTUAL